Alexandra Hughes-Wilson

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandra Hughes-Wilson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Chief Patient Access and Commercial Planning Share Options (Right to buy) 195,000 $155,540 $1.01 01 Feb 2026 Direct

Insider Reports Filed by Alexandra Hughes-Wilson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MREO Mereo BioPharma Group plc 01 Feb 2026 3 $0 4 Chief Patient Access and Commercial Planning 02 Feb 2026, 16:30
MREO Mereo BioPharma Group plc 25 Jan 2025 1 $0 4 Chief Patient Access and Commercial Planning 28 Jan 2025, 16:05
MREO Mereo BioPharma Group plc 12 Sep 2024 4 -$637,203 4 Chief Patient Access and Commercial Planning 16 Sep 2024, 20:46
MREO Mereo BioPharma Group plc 11 Sep 2024 6 $0 4 Chief Patient Access and Commercial Planning 13 Sep 2024, 16:47
MREO Mereo BioPharma Group plc 25 Jun 2024 2 -$115,369 4 Chief Patient Access and Commercial Planning 27 Jun 2024, 16:15
MREO Mereo BioPharma Group plc 21 Jun 2024 2 $0 4 Chief Patient Access and Commercial Planning 25 Jun 2024, 18:13
MREO Mereo BioPharma Group plc 22 May 2024 0 $0 4/A Chief Patient Access and Commercial Planning 11 Jun 2024, 16:18
MREO Mereo BioPharma Group plc 22 May 2024 8 -$383,131 4 Chief Patient Access and Commercial Planning 23 May 2024, 21:54
MREO Mereo BioPharma Group plc 25 Jan 2024 1 $0 4 Chief Patient Access and Commercial Planning 26 Jan 2024, 16:15
MREO Mereo Biopharma Group plc 01 Jan 2024 0 $0 3 Chief Patient Access and Commercial Planning Exhibit 24 - Power of Attorney 02 Jan 2024, 16:16